IMPROVE-IT

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes - The New England Journal of Medicine - 2015

Brief Summary:

Among individuals with recent ACS, the addition of ezetimibe to moderate-intensity statin therapy is associated with a reduction in CV mortality, major CV event, or nonfatal stroke when compared to statin therapy alone.

Reference:
http://www.ncbi.nlm.nih.gov/pubmed/26039521